By comparing lung tissue samples from PAH and non-PAH patients, Vallance et al. demonstrated that in PAH, NOX1-induced hypoxia activates SP1, promoting SP1 binding to the CXCL12 promoter and inducing CXCL12 transcription. The gene discussed is SP1; the disease is pulmonary arterial hypertension.